Main > RHEUMATOLOGY>RHEUMATOID ARTHRITIS > Treatment > RANK Ligand (RANKL). > RANKL MAb-Type Inhibitor > Co.: USA. A (Phase II/Patents) > Patent > Total No. of U.S. Patents: 20

---

Total No. of U.S. Patents: 20's products
This section has no products